Delivery Order SPE2DB20D6037-SPE2DB25FTUR0

Award Date 2/5/25
Potential Completion Date 2/6/25
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order (SPE2DB20D9371|SPE2DB25FT1U9) issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract has a ceiling value of $1,436.40 and covers the delivery of 4,567,005,555 units of Fexofenadine HCL 180 mg tablets. The contract is a firm fixed-price award, with a period of performance through January 17, 2025. DMS Pharmaceutical Group Inc. has a significant...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,436.40 contract covers the delivery of 500 tablets of fexofenadine hydrochloride 180 mg to support the medical supply needs of military healthcare facilities. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract has a ceiling value of $1,436.40 and an ultimate completion date of February 10, 2025. The contract is for the supply of 4,567,248,727 units of Fexofenadine HCL 180 mg tablets, a pharmaceutical product. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,436.40 contract covers the delivery of 4,567,133,666 units of Fexofenadine HCL 180 mg tablets to support the medical supply needs of military healthcare facilities. The contract is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a Delivery Order (DO) with a Firm Fixed Price (FFP) pricing type, valued at $1,923.36, for the delivery of FEXOFENADINE HCL 180 MG TABLET 500S. The contract has an ultimate completion date of January 13, 2025. This award is not associated with a specific set-aside designation. DMS...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois, is a delivery order valued at $2,460.12 issued by the Defense Logistics Agency (DLA). The contract is for the delivery of 4,567,324,784 tablets of the pharmaceutical drug Fexofenadine HCL 180 mg and has a completion date of January 31, 2025. The contract is not associated with any set-aside designation. It is part of a larger $499,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order valued at $1,413.24 for the supply of pharmaceutical products, including medications such as fluticasone propionate. The contract was awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain program, which supports the recurring medical supply needs of military health facilities and VA medical centers nationwide. The contract is a firm...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $1,990.56 under an indefinite delivery contract with the Defense Logistics Agency to supply 8503563711 FEXOFENADINE HYDROC to Defense Logistics Agency Troop Support Medical. As a woman owned small business and woman owned business, DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that holds this indefinite delivery contract with the Defense Logistics Agency through December 2025 to provide...
This federal contract award is a $624,516.90 firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The delivery order, which is not associated with any set-aside designation, was awarded under DMS Pharmaceutical Group's existing $499,999,999 Indefinite Delivery Contract (IDC) with the DLA for the provision of a comprehensive range of pharmaceutical products, including branded and...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the delivery of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. The contract, valued at $5,473.00, is a delivery order awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain program. The contract has no set-aside designation and is a firm fixed-price contract. DMS Pharmaceutical...
  • SPE2DB20D6037
    Indefinite Delivery Contract
  • SPE2DB20D6037-SPE2DB25FTUR0
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The award is a delivery order valued at $1,903.78 for the provision of Fexofenadine HCL 180 mg tablets. The contract is a firm fixed-price delivery order that does not have a set-aside designation.

DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The contract covers an extensive portfolio of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. DMS Pharmaceutical Group's extensive experience and federal contract history position the company as a crucial supplier in the federal pharmaceutical supply chain, providing direct distribution of prescription drugs and pharmacy services to Department of Defense healthcare sites.

Generated 5/7/25, 9:58 AM